« Back
Home /
N-Desethyl Sunitinib

N-Desethyl Sunitinib

Item no.	TMO-T12145-50mg
Manufacturer	TargetMol
CASRN	356068-97-8
Amount	50 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Testicular & Prostate Cancer
Type	Molecules
Format	Powder
Specific against	other
Purity	0,98
Smiles	C(=C\1/C=2C(NC1=O)=CC=C(F)C2)\C3=C(C)C(C(NCCNCC)=O)=C(C)N3
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	SU11662,SU-11662
Shipping Condition	Cool pack
Available
Manufacturer - Targets	PDGFR\|\|\|Drug Metabolite\|\|\|c-Kit\|\|\|VEGFR\|\|\|FLT
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	370.42
Description	N-Desethyl Sunitinib (SU012662) is the primary active metabolite of Sunitinib produced by the metabolism of cytochrome P450 enzyme 3A4 (CYP3A4).Sunitinib is an orally available inhibitor of a number of tyrosine kinases involved in tumor proliferation and angiogenesis, including VEGFR, PDGFR, KIT, and FLT3, and was approved for the treatment of advanced/metastatic renal cell carcinoma (RCC)
Pathways	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis\|\|\|Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T12145-50mg-datasheet.pdf

TMO-T12145-50mg-safety-datasheet.pdf